Advanced Solid Tumors

Showing NaN - NaN of 76

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +3 more
  • San Antonio, Texas
  • +1 more
Sep 8, 2023

Advanced Solid Tumors Trial in Worldwide (BGB-30813, Tislelizumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Hackensack, New Jersey
  • +10 more
Jun 6, 2023

Advanced Solid Tumors, NSCLC Trial in Israel, United States (BAY2862789)

Not yet recruiting
  • Advanced Solid Tumors
  • Non-small Cell Lung Cancer
  • Detroit, Michigan
  • +5 more
May 5, 2023

Advanced Solid Tumors Trial in United States (REGN7075, cemiplimab)

Recruiting
  • Advanced Solid Tumors
  • San Francisco, California
  • +9 more
Jan 30, 2023

Advanced Solid Tumors Trial in Switzerland, United States (Debio 0123)

Recruiting
  • Advanced Solid Tumors
  • Debio 0123
  • Grand Rapids, Michigan
  • +3 more
Jan 27, 2023

Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)

Recruiting
  • Advanced Solid Tumors
  • +5 more
  • Scottsdale, Arizona
  • +7 more
Jan 23, 2023

Advanced Solid Tumors Trial in Japan, United Kingdom, United States (BAY2965501)

Recruiting
  • Advanced Solid Tumors
  • Denver, Colorado
  • +5 more
Jan 19, 2023

Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Philadelphia, Greenville, San Antonio (AMG 820)

Completed
  • Advanced Malignancy
  • +5 more
  • AMG 820
  • Philadelphia, Pennsylvania
  • +2 more
Jan 18, 2023

Advanced Solid Tumors Trial in Worldwide (MK-1088, Pembrolizumab)

Recruiting
  • Advanced Solid Tumors
  • Miami, Florida
  • +10 more
Jan 12, 2023

Advanced Solid Tumors Trial in Worldwide (ASP1948, nivolumab, pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • New Haven, Connecticut
  • +41 more
Jan 10, 2023

Advanced Solid Tumors Trial in Worldwide (BMS-986360, Docetaxel, Nivolumab)

Recruiting
  • Advanced Solid Tumors
  • Los Angeles, California
  • +15 more
Jan 9, 2023

Advanced Solid Tumors Trial in Worldwide (ASP1951, pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • Tucson, Arizona
  • +31 more
Jan 10, 2023

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +3 more
  • Boston, Massachusetts
  • +9 more
Dec 22, 2022

Advanced Solid Tumors Trial in United States (ABBV-706, Cisplatin, Budigalimab)

Recruiting
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +3 more
Dec 13, 2022

Advanced Solid Tumors Trial in New Zealand, United States (GS-4224)

Terminated
  • Advanced Solid Tumors
  • Encinitas, California
  • +5 more
Sep 9, 2022

Advanced Solid Tumors Trial in Canada, Singapore, United States (BAY3375968, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Chicago, Illinois
  • +4 more
Sep 9, 2022

Advanced Solid Tumors Trial in Worldwide (Quavonlimab, Pembrolizumab, Pembrolizumab/Quavonlimab)

Active, not recruiting
  • Advanced Solid Tumors
  • Quavonlimab
  • +2 more
  • Gilbert, Arizona
  • +52 more
Aug 18, 2022

Advanced Solid Tumors Trial in United States (GS-3583)

Active, not recruiting
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +3 more
Jul 22, 2022

Advanced Solid Tumors, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Gastrointestinal (GI) Malignancies Trial in

Recruiting
  • Advanced Solid Tumors
  • +2 more
  • Los Angeles, California
  • +31 more
Jul 20, 2022

Advanced Solid Tumors Trial in United States (ADCT-901)

Recruiting
  • Advanced Solid Tumors
  • Denver, Colorado
  • +6 more
Jul 18, 2022

Advanced Solid Tumors Trial in Houston, San Antonio, Toronto (M4076)

Recruiting
  • Advanced Solid Tumors
  • Houston, Texas
  • +2 more
Jul 13, 2022

Advanced Solid Tumors Trial in China, Taiwan, United States (IMP7068)

Recruiting
  • Advanced Solid Tumors
  • Atlanta, Georgia
  • +14 more
Jul 13, 2022

NSCLC, Advanced Solid Tumors, Gastroesophageal Adenocarcinoma Trial in Worldwide (ABBV-400)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Santa Monica, California
  • +25 more
Jun 27, 2022

Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)

Terminated
  • Advanced Solid Tumors
  • Los Angeles, California
  • +29 more
May 21, 2022

Advanced Solid Tumors Trial in Grand Rapids, Houston, San Antonio (CPI-1205, ipilimumab)

Completed
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +2 more
May 16, 2022